Bioyong Technology Co., Ltd.

https://www.bioyong.com

Bioyong Technology Company, Ltd has dedicated itself to developing mass spectrometry technologies for more than a decade. With the only/unique CFDA approval of domestic MALDI platform so far, Bioyong has expertise in serum peptidomics, nucleic acid detection and microorganism identifications. These technologies can and have been applied extensively in the growing field of precision medicine in an attempt to improve both diagnosis and prognosis for patients with a broad range of diseases. We are working hard to make the world healthier. *

	Start	2015-04-27 existent
	Industry	analytical services
	Industry 2	mass spectrometry services (MS services)
	Person	Ma, Qingwei (Bioyong Technology 201504 CEO + Founder)

	Region	Beijing (Peking)
	Country	China
	City	n. a. Beijing
	Tel	+86-10-82608397
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Biodesix, Inc.. (1/9/17). "Press Release: Biodesix and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat Test in Greater China".

		Record changed: 2019-06-09

Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Bioyong Technology Co., Ltd.

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com